Oviedo Medical Research

What Oviedo Medical Research does

Oviedo Medical Research is a privately held, physician-affiliated clinical research site founded in 1997 and headquartered in Oviedo, Florida (2441 W. State Rd 426, Suite 2011). The company specializes in conducting Phase II through IV clinical trials as a third-party independent research site, evaluating medications, treatments, and medical devices for safety and efficacy on behalf of pharmaceutical and biotech sponsors. Since inception, the affiliated physicians have conducted more than 100 trials spanning therapeutic areas including diabetes, obesity, cardiovascular disease, respiratory, neurological, gastrointestinal, dermatological, and endocrine conditions. The organization is operationally intertwined with Block, Nation, Chase and Smolen Family Medicine, whose physicians — Dr. Bradley M. Block, Dr. Craig P. Chase, Dr. Amy J. Nation, and Dr. Susan G. Smolen — serve as principal and sub-investigators.

The current active trial pipeline is concentrated in metabolic disease, including an oral GLP-1 weight loss study, a GLP-1 Type 2 diabetes study, a creatinine device study, and forthcoming Type 2 diabetes device and oral insulin studies. There is no proprietary technology platform disclosed; the company's core asset is its investigator team, with Dr. Chase alone credited on over 90 clinical trials. Participant enrollment is handled direct-to-consumer through the company website, supplemented by referrals from the affiliated family medicine practice, with a 30-minute phone pre-screening followed by an on-site screening visit.

The business model is a professional services arrangement: pharmaceutical and biotech sponsors fund all study-related costs (physician visits, diagnostics, investigational medication), and Oviedo retains a share of per-patient study budgets as a site fee. Participants themselves are not charged and receive approximately $50+ per visit as compensation for time and travel. Revenue is not publicly disclosed; the firm operates with 1–10 employees and has no external institutional investment, M&A activity, or parent company involvement indicated. Marketing is limited to website content, a physician-authored health blog, and downloadable patient forms.

Name

Oviedo Medical Research

Legal name

Oviedo Medical Research

Website

https://oviedomedicalresearch.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

1–10 employees

Short description

Oviedo Medical Research is a physician-owned, independent clinical research site in Oviedo, Florida, founded in 1997. It conducts Phase II–IV trials for pharmaceutical and biotech sponsors across metabolic, cardiovascular, and other therapeutic areas, affiliated with Block, Nation, Chase & Smolen Family Medicine.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)

Keywords

• Clinical research services
• Phase II-IV clinical trials
• Pharmaceutical trial site
• Medical research site
• Biotech clinical studies

Headquarters

HQ city

Oviedo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Trial Services: Oviedo Medical Research conducts Phase II through IV clinical trials as a third-party independent research site. They partner with pharmaceutical and biotech companies (described as 'world-renowned' and 'small, emerging biotechnical companies') who fund the studies. The pharmaceutical companies cover all study-related costs for patients, including doctor visits, diagnostic tests, and study medication. This allows the company to operate without charging participants while generating revenue from pharma/biotech sponsors.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Oviedo Medical Research is an independent clinical research site that conducts Phase II through Phase IV FDA-regulated clinical trials for pharmaceutical and biotechnology sponsors across multiple therapeutic areas. The site is closely affiliated with Block, Nation, Chase & Smolen Family Medicine, which provides a steady patient pipeline. Sponsored clinical trial participation is free to enrolled volunteers, who receive modest compensation for time and travel.

Product overview

Oviedo Medical Research operates as a clinical research organization offering Phase II-IV clinical trials. The company partners with pharmaceutical and biotech companies to evaluate medications, treatments, and medical devices for FDA approval across multiple therapeutic areas including diabetes, obesity, cardiovascular disease, respiratory conditions, neurological disorders, and more. They provide clinical trial participation opportunities with compensation for eligible volunteers.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase II-IV Sponsored Clinical Trials Sponsored, FDA-regulated clinical research studies conducted on-site in Oviedo, Florida, serving pharmaceutical and biotechnology companies across Phase II-IV studies in cardiovascular, metabolic, respiratory, dermatology, and women's health therapeutic areas.
• Cardiovascular Clinical Trials (Aortic Stenosis, Heart Failure) Sponsor-funded clinical trials targeting aortic stenosis and heart failure, designed for adult patients with these cardiovascular conditions, conducted under FDA-regulated Phase II-IV protocols.
• Diabetes Clinical Trials Clinical research studies for patients with diabetes, sponsored by pharmaceutical and biotechnology companies, conducted under FDA-regulated protocols at the Oviedo site.
• Hypertension Clinical Trials Clinical research studies for patients with high blood pressure, sponsored by pharmaceutical and biotechnology companies, conducted under FDA-regulated protocols at the Oviedo site.
• Respiratory Clinical Trials (RSV, COPD, Asthma) Sponsor-funded respiratory clinical trials covering RSV, COPD, and asthma for affected adult patients, conducted under FDA-regulated Phase II-IV protocols at the Oviedo site.
• Women's Health Clinical Trials Sponsor-funded clinical trials in women's health therapeutic areas, conducted under FDA-regulated protocols for eligible women in the Central Florida region.
• Gastroenterology Clinical Trials (Acid Reflux, Irritable Bowel Syndrome) Sponsor-funded gastroenterology trials for acid reflux and irritable bowel syndrome (IBS) patients, conducted under FDA-regulated protocols at the Oviedo site.
• Dermatology Clinical Trials (Eczema) Sponsor-funded dermatology clinical trial for eczema patients, conducted under FDA-regulated protocols at the Oviedo site.
• Influenza Vaccine Clinical Trial Sponsor-funded clinical trial for influenza vaccine candidates, conducted under FDA-regulated protocols at the Oviedo site.

Quantifiable outcome

• More than 100 clinical trials conducted since 1997
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• Pharmaceutical Companies (World-renowned)coreStrategic or Co-development PartnerOviedo Medical Research partners with large pharmaceutical companies to conduct Phase II-IV clinical trials. These sponsors fund all study-related costs for patients including doctor visits, diagnostic tests, and study medication.
• Emerging Biotechnology CompaniescoreStrategic or Co-development PartnerThe company also partners with small, emerging biotech companies to facilitate their clinical development programs. These partnerships help bring innovative treatments through the FDA approval process.
• Block, Nation, Chase & Smolen Family MedicinecoreStrategic or Co-development PartnerThe research organization is affiliated with this family medicine practice whose doctors conduct the clinical trials. The practice has been performing research trials since 1997 and provides patient referrals and medical infrastructure.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Meridien Research: Multi-site clinical research site network conducting Phase II–IV trials across multiple therapeutic areas for pharma/biotech sponsors, with a similar investigator-led operating model and patient-recruitment strategy.
• Velocity Clinical Research: One of the largest U.S. clinical research site networks operating dedicated Phase II–IV sites. Like Oviedo, it partners with pharma and biotech sponsors to conduct trials at owned sites, but at substantially greater scale and geographic reach.
• Benchmark Research: Network of dedicated clinical research sites conducting Phase II–IV trials for pharma sponsors; comparable site model, therapeutic focus, and patient-recruitment playbook.
• Flourish Research: Southeast U.S.-focused integrated research site network running Phase II–IV trials in obesity, diabetes, and cardiometabolic indications — directly comparable site model, therapeutic mix, and sponsor relationships.
• Accel Research Sites: Multi-site clinical research organization headquartered in Florida operating Phase II–IV trials across therapeutic areas including endocrinology and metabolic disease — direct overlap with Oviedo Medical Research's GLP-1, diabetes, and obesity portfolio.
• Clinical Trials of America: Independent multi-specialty clinical research site network running Phase II–IV trials across a broad therapeutic mix with the same sponsor-paid business model.
• PMG Research: Established U.S. site network (now part of Alcanza Clinical Research) running Phase II–IV trials; serves the same pharma/biotech sponsors as Oviedo from owned dedicated research sites.

Broad incumbents

• IQVIA (Site Management): Global CRO and site-services organization that runs and supports a large dedicated site network; Oviedo competes with IQVIA-affiliated investigator sites for the same pharma/biotech Phase II–IV sponsorships.
• University of Florida Clinical Research Center: Large academic research enterprise in Florida operating Phase I–IV trials; competes with Oviedo for the same sponsor-funded Phase II–IV work in Central Florida, but with significantly greater scale and academic capabilities.
• Privia Health Clinical Research: Large U.S. physician-enablement platform with embedded clinical research across its medical group footprint; competes for the same sponsor trials and investigator talent as Oviedo, but as part of a much broader care delivery and technology platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/OMRstudy
• LinkedInlinkedin.com/company/oviedo-medical-research

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oviedo Medical Research